108 related articles for article (PubMed ID: 18179135)
1. Comparison of the molecular classification with FIGO stage and histological grade on endometrial cancer.
Cai B; Liu L; Xi W; Zhu YP; Lu GZ; Yang YX; Wan XP
Eur J Gynaecol Oncol; 2007; 28(6):451-60. PubMed ID: 18179135
[TBL] [Abstract][Full Text] [Related]
2. [Study of differential gene expression in different stage human endometrial cancer].
Wan XP; Cai B; Liu L; Xi XW; Yang YX
Zhonghua Fu Chan Ke Za Zhi; 2006 Jan; 41(1):38-42. PubMed ID: 16635327
[TBL] [Abstract][Full Text] [Related]
3. Molecular classification of human endometrial cancer based on gene expression profiles from specialized microarrays.
Yao Y; Chen Y; Wang Y; Li X; Wang J; Shen D; Wei L
Int J Gynaecol Obstet; 2010 Aug; 110(2):125-9. PubMed ID: 20471643
[TBL] [Abstract][Full Text] [Related]
4. Use of gene expression profiles to stage concurrent endometrioid tumors of the endometrium and ovary.
Guirguis A; Elishaev E; Oh SH; Tseng GC; Zorn K; DeLoia JA
Gynecol Oncol; 2008 Feb; 108(2):370-6. PubMed ID: 18083218
[TBL] [Abstract][Full Text] [Related]
5. Molecular subtypes identified by gene expression profiling in early stage endometrioid endometrial adenocarcinoma.
Gao BR; Chen YH; Yao YY; Li XP; Wang JL; Wei LH
Chin Med J (Engl); 2013; 126(19):3680-4. PubMed ID: 24112163
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiling of endometrial adenocarcinomas reveals increased apolipoprotein E expression in poorly differentiated tumors.
Huvila J; Brandt A; Rojas CR; Pasanen S; Talve L; Hirsimäki P; Fey V; Kytömäki L; Saukko P; Carpén O; Soini JT; Grénman S; Auranen A
Int J Gynecol Cancer; 2009 Oct; 19(7):1226-31. PubMed ID: 19823059
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiling in human endometrial cancer tissue samples: utility and diagnostic value.
Smid-Koopman E; Blok LJ; Helmerhorst TJ; Chadha-Ajwani S; Burger CW; Brinkmann AO; Huikeshoven FJ
Gynecol Oncol; 2004 May; 93(2):292-300. PubMed ID: 15099936
[TBL] [Abstract][Full Text] [Related]
8. [Expression profile of genes associated with the histaminergic system estimated by oligonucleotide microarray analysis HG-U133A in women with endometrial adenocarcinoma].
Jeda A; Witek A; Janikowska G; Cwynar G; Janikowski T; Ciałon M; Orchel J; Mazurek U
Ginekol Pol; 2014 Mar; 85(3):172-9. PubMed ID: 24783427
[TBL] [Abstract][Full Text] [Related]
9. Mutation status coupled with RNA-sequencing data can efficiently identify important non-significantly mutated genes serving as diagnostic biomarkers of endometrial cancer.
Liu K; He L; Liu Z; Xu J; Liu Y; Kuang Q; Wen Z; Li M
BMC Bioinformatics; 2017 Dec; 18(Suppl 14):472. PubMed ID: 29297280
[TBL] [Abstract][Full Text] [Related]
10. Microarray analysis of endometrial carcinomas and mixed mullerian tumors reveals distinct gene expression profiles associated with different histologic types of uterine cancer.
Maxwell GL; Chandramouli GV; Dainty L; Litzi TJ; Berchuck A; Barrett JC; Risinger JI
Clin Cancer Res; 2005 Jun; 11(11):4056-66. PubMed ID: 15930340
[TBL] [Abstract][Full Text] [Related]
11. Microarray analysis reveals distinct gene expression profiles among different tumor histology, stage and disease outcomes in endometrial adenocarcinoma.
Mhawech-Fauceglia P; Wang D; Kesterson J; Clark K; Monhollen L; Odunsi K; Lele S; Liu S
PLoS One; 2010 Nov; 5(11):e15415. PubMed ID: 21079744
[TBL] [Abstract][Full Text] [Related]
12. A binary architectural grading system for uterine endometrial endometrioid carcinoma has superior reproducibility compared with FIGO grading and identifies subsets of advance-stage tumors with favorable and unfavorable prognosis.
Lax SF; Kurman RJ; Pizer ES; Wu L; Ronnett BM
Am J Surg Pathol; 2000 Sep; 24(9):1201-8. PubMed ID: 10976693
[TBL] [Abstract][Full Text] [Related]
13. Is the 2009 FIGO staging system really valuable for stage I endometrial cancer?
Atalay F; Cetinkaya K; Bacinoglu A
Eur J Gynaecol Oncol; 2013; 34(6):556-8. PubMed ID: 24601051
[TBL] [Abstract][Full Text] [Related]
14. The reproducibility of histological parameters employed in the novel binary grading systems of endometrial cancer.
Gemer O; Uriev L; Voldarsky M; Gdalevich M; Ben-Dor D; Barak F; Anteby EY; Lavie O
Eur J Surg Oncol; 2009 Mar; 35(3):247-51. PubMed ID: 18775628
[TBL] [Abstract][Full Text] [Related]
15. Expression of tumor suppressor genes related to the cell cycle in endometrial cancer patients.
Witek Ł; Janikowski T; Bodzek P; Olejek A; Mazurek U
Adv Med Sci; 2016 Sep; 61(2):317-324. PubMed ID: 27218895
[TBL] [Abstract][Full Text] [Related]
16. Reproducibility of grading systems for endometrial endometrioid carcinoma and their relation with pathologic prognostic parameters.
Kapucuoglu N; Bulbul D; Tulunay G; Temel MA
Int J Gynecol Cancer; 2008; 18(4):790-6. PubMed ID: 17892460
[TBL] [Abstract][Full Text] [Related]
17. HER-2 is an independent prognostic factor in endometrial cancer: association with outcome in a large cohort of surgically staged patients.
Morrison C; Zanagnolo V; Ramirez N; Cohn DE; Kelbick N; Copeland L; Maxwell GL; Fowler JM
J Clin Oncol; 2006 May; 24(15):2376-85. PubMed ID: 16710036
[TBL] [Abstract][Full Text] [Related]
18. p53, estrogen and progesterone receptors in diagnostic curettage for endometrial adenocarcinoma and their correlation with morphological data and disease stage at hysterectomy.
Bonfitto VL; de Angelo Andrade LA
Sao Paulo Med J; 2003 Jul; 121(4):163-6. PubMed ID: 14595509
[TBL] [Abstract][Full Text] [Related]
19. Prediction of lymph node metastasis in patients with endometrioid endometrial cancer using expression microarray.
Bidus MA; Risinger JI; Chandramouli GV; Dainty LA; Litzi TJ; Berchuck A; Barrett JC; Maxwell GL
Clin Cancer Res; 2006 Jan; 12(1):83-8. PubMed ID: 16397028
[TBL] [Abstract][Full Text] [Related]
20. Comparison of FIGO 1989 and 2009 recommendations on staging of endometrial carcinoma: pathologic analysis and cervical status in 123 consecutive cases.
Korczynski J; Jesionek-Kupnicka D; Gottwald L; Piekarski J
Int J Gynecol Pathol; 2011 Jul; 30(4):328-34. PubMed ID: 21623209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
